Comparing shockwave therapy and ultrasound-guided oxygen-ozone injection for tennis elbow
Official title: Comparison of the Efficacy of Extracorporeal Shock Wave Therapy (ESWT) and Ultrasound-Guided Ozone Injection Therapy in Patients With Resistant Lateral Epicondylitis
Run by Ankara City Hospital Bilkent · NCT07427368 · Data updated 2026-11-12
This trial will see if shockwave therapy or an ultrasound-guided oxygen-ozone injection helps adults with chronic tennis elbow who haven't improved with standard treatments.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Ankara City Hospital Bilkent Academic / other |
| Locations | 1 site (Ankara) |
| Status | Recruiting |
| Started | June 1, 2025 |
| Main results expected | March 3, 2026 |
| Study ends | March 3, 2026 |
| Registry record updated | February 23, 2026 |
| Trial ID | NCT07427368 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 with lateral epicondylitis lasting more than three months who have not responded to standard conservative treatments and who have no recent steroid injections or other elbow pathology.
✕Probably not a fit
People with acute elbow symptoms, other elbow conditions, prior elbow surgery, systemic inflammatory disease, or a corticosteroid injection within the past six months are unlikely to benefit from these specific interventions.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with chronic lateral epicondylitis who have failed first-line conservative care are randomized to receive either extracorporeal shock wave therapy (ESWT) or an ultrasound-guided oxygen-ozone injection once weekly for three weeks. Clinical outcomes (pain and function) and tendon structure on ultrasound are measured to compare the two approaches. ESWT is intended to stimulate tissue repair and modulate pain pathways, while ozone injections are proposed to reduce inflammation and improve local oxygenation and fibroblast activity. The trial targets treatment-resistant cases to identify minimally invasive alternatives to surgery.
Why it matters
Potential benefit: If successful, one of these treatments could offer a safer, minimally invasive option that reduces pain and improves function in people with chronic, treatment‑resistant tennis elbow.
How similar studies have gone: ESWT has moderate supportive evidence for chronic tendinopathies while oxygen-ozone injection data are smaller and mixed, and direct head-to-head comparisons are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age: Male or female patients between 18 and 65 years of age. * Clinical Diagnosis: Patients diagnosed with lateral epicondylitis, defined by pain in the lateral epicondyle region for more than 3 months, increased pain on palpation of the lateral epicondyle, and positive provocation tests (Cozen's, Maudsley's, or Mills' tests). * Symptom Duration: Presence of symptoms for more than 3 months (resistant cases). * Treatment Failure: Lack of response to first-line conservative treatments (e.g., analgesics, exercise, rest, splinting). * Radiographic Confirmation: No other pathology detected on direct radiographs of the elbow. * Injection History: No corticosteroid injection to the affected elbow within the last 6 months. * Consent: Voluntary participation in the study Exclusion Criteria: * Elbow Pathology: Presence of elbow problems other than lateral epicondylitis (e.g., loose bodies, rheumatoid nodules). * Surgical History: History of previous surgery on the affected elbow joint. * Structural Damage: Presence of tendon rupture. * Consent: Unwillingness to continue treatment or participate. * Spinal Pathology: Cervical root pathology (cervical radiculopathy). * Neuropathy: Diagnosed upper extremity entrapment neuropathy. * Neurological Status: Presence of neurological impairment or deficits. * Recent Injections: History of injection therapy to the elbow within the last 6 months. * Recent Therapy: History of physical therapy for the elbow region within the last 6 months. * Pregnancy: Pregnant women. * Hematological: Presence of coagulation or bleeding disorders. * Vascular: Presence of peripheral vasculopathy. * Pain Syndromes: Presence of Complex Regional Pain Syndrome (CRPS). * Oncology: History of malignancy. * Systemic Diseases: Presence of systemic inflammatory or autoimmune disorders (e.g., Rheumatoid Arthritis, SLE). * Trauma: History of direct trauma to the elbow. * Medication: Current use of medications that may affect pain levels or muscle strength (e.g., muscle relaxants, analgesics, gabapentinoids). * Local Infection: Presence of open wounds, infection, or signs of active inflammation in the elbow region. * Cooperation: Difficulty in cooperation or cognitive inability to follow instructions. * Enzyme Deficiency: Congenital Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency.
Where it's running
-
Ankara Bilkent City Hospital
Ankara, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Berke Aras, Medical Doctor — Ankara City Hospital Bilkent
- Study coordinator: Duygu Elbaşı, Medical Doctor
- Email: duyguelbasi@gmail.com
- Phone: +905544739970
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Platelet-rich plasma treatment for patellar, Achilles, elbow (epicondylitis), and plantar heel tendinopathies.
This multicenter observational project will try platelet-rich plasma (PRP) injections to see if they reduce pain and improve function in adults with chronic patellar, Achilles, lateral elbow (epicondylitis), or plantar heel (fasciitis) tendinopathies.
-
Comparing shock wave treatments for elbow pain
This study is testing two types of shock wave treatments for elbow pain to see which one works better for people with this condition.
-
Video-Only vs Standard Informed Consent for Amniocentesis or CVS in Pregnant Women
This study tests whether video-based education helps reduce anxiety and improve decision readiness for invasive prenatal testing in pregnant women.
-
Extracorporeal Shock Wave Therapy With or Without Kinesio Taping for Plantar Fasciitis
This study tests whether adding kinesio taping to shock wave therapy helps reduce pain and improve foot function in people with plantar fasciitis.
-
ESWT added to standard lymphedema care for breast cancer patients
This study tests whether adding extracorporeal shock wave therapy to standard lymphedema care helps women with unilateral Stage II breast cancer–related swelling.
-
Postoperative Pain Control in Elderly Knee Replacement
This study tests two pain-management methods after knee replacement in adults 60 and older to see which one reduces delirium and improves recovery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.